InMed Pharmaceuticals (INM) Cash & Equivalents Growth (1y) (2021 - 2026)
Analysis
InMed Pharmaceuticals (INM) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.18 Bn | 142.67 Bn | 1.63 Bn | 67.94% |
| 2 | Ati | 28.28 Bn | 27.50 Bn | 309.80 Mn | 144.99% |
| 3 | Qnity Electronics | 26.28 Bn | 25.32 Bn | 666.00 Mn | - |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | -30.27% |
| 5 | DuPont de Nemours | 17.40 Bn | 15.66 Bn | 639.00 Mn | -5.28% |
| 6 | Avery Dennison | 12.97 Bn | 12.74 Bn | 729.40 Mn | 5.28% |
| 7 | Solstice Advanced Materials | 10.03 Bn | 9.28 Bn | 370.00 Mn | - |
| 8 | Element Solutions | 8.73 Bn | 8.54 Bn | 334.00 Mn | -64.22% |
| 9 | Eastman Chemical | 7.82 Bn | 7.13 Bn | 560.00 Mn | 63.36% |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | 10.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64% |
| Dec 31, 2025 | 100.00% |
| Sep 30, 2025 | 67.86% |
| Jun 30, 2025 | 63.48% |
| Mar 31, 2025 | -38.16% |
| Dec 31, 2024 | -63.29% |
| Sep 30, 2024 | -16.89% |
| Jun 30, 2024 | -26.27% |
| Mar 31, 2024 | -21.21% |
| Dec 31, 2023 | -17.09% |
| Sep 30, 2023 | -27.94% |
| Jun 30, 2023 | 44.29% |
| Mar 31, 2023 | 62.29% |
| Dec 31, 2022 | 1.54% |
| Sep 30, 2022 | -39.24% |
| Jun 30, 2022 | -16.11% |
| Mar 31, 2022 | -37.43% |
| Dec 31, 2021 | 12.51% |
| Sep 30, 2021 | 238.93% |
| Jun 30, 2021 | 26.82% |